Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy

BJU International

Volumn 105, Issue 8, 2010, Pages 1102-1106

  Abe, Takashige ^c   Shinohara, Nobuo ^c   Harabayashi, Toru ^c   Sazawa, Ataru ^c   Akino, Tomoshige ^c   Ishikawa, Shuhei ^c   Kubota, Kanako ^a   Matsuno, Yoshihiro ^a   Osawa, Takahiro ^b   Shibata, Takeshi ^b   Toyoda, Yutaka ^b   Shinno, Yuichiro ^b   Kamota, Shinji ^c   Minami, Keita ^b   Sakashita, Shigeo ^b   Kumagai, Akira ^b   Takada, Norikata ^b   Togashi, Masaki ^b   Sano, Hiroshi ^b   Mori, Tatsuya ^b   Nonomura, Katsuya ^c   more..

^a HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^b Hokkaido Urothelial Cancer Research Group   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder cancer; Progression; Recurrence; Upper urinary tract cancer

Indexed keywords

BCG VACCINE; EPIRUBICIN;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CARCINOMA IN SITU; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISTANT METASTASIS; FEMALE; FISHER EXACT TEST; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEPHROURETERECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; URINARY TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; URETER; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 77950197054     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08836.x     Document Type: Article

References (19)

1. Sakamoto N, Naito S, Kotoh S et al. Recurrence of bladder tumours following surgery for transitional cell carcinoma of the upper urinary tract. Eur Urol 1991 20 : 136 139
2. Krogh J, Kvist E, Rye B. Transitional cell carcinoma of the upper urinary tract: prognostic variables and post-operative recurrences. Br J Urol 1991 67 : 32 6
3. Mukamel E, Simon D, Edelman A, Konichezky M, Hadar H, Servadio C. Metachronous bladder tumors in patients with upper urinary tract transitional cell carcinoma. J Surg Oncol 1994 57 : 187 190
4. Racioppi M, D'Adessi A, Alcini A, Destito A, Alcini E. Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumours. Br J Urol 1997 80 : 707 711
5. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998 52 : 594 601
6. Hisataki T, Miyao N, Masumori N et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology 2000 55 : 663 667
7. Jarrett TW, Chan DY, Cadeddu JA, Kavoussi LR. Laparoscopic nephroureterectomy for the treatment of transitional cell carcinoma of the upper urinary tract. Urology 2001 57 : 448 453
8. Koga F, Nagamatsu H, Ishimaru H, Mizuo T, Yoshida K. Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract. Urol Int 2001 67 : 135 141
9. Kang CH, Yu TJ, Hsieh HH et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 2003 98 : 1620 1626
10. Matsui Y, Utsunomiya N, Ichioka K et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005 65 : 279 283
11. Raman JD, Ng CK, Boorjian A, Vaughan ED, Sosa RE, Scherr DS. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int 2005 96 : 1031 1035
12. Tsai YS, Tzai TS, Chow NH, Wu CL. Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract. Urology 2005 66 : 1197 1202
13. Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 2006 98 : 1181 1186
14. Sobin LH, Wittekind CH eds. International Union Against Cancer TNM Classification of Malignant Tumors, 5th edn. New York : John Wiley & Sons, 1997 : 170 173
15. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998 22 : 1435 1448
16. Raman JD, Sosa RE, Vaughan ED Scherr DS. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Urology 2007 69 : 251 254
17. Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000 163 : 73 8
18. Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL, Debruyne FM. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 1993 150 : 60 4
19. Kiemeney LA, Witjes JA, Heijbroek RP, Koper NP, Verbeek AL, Debruyne FM. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urology Group. Br J Urol 1994 73 : 164 171